Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis ofp16

2016 ◽  
Vol 44 (7) ◽  
pp. 591-598 ◽  
Author(s):  
Kenzo Hiroshima ◽  
Di Wu ◽  
Mizue Hasegawa ◽  
Eitetsu Koh ◽  
Yasuo Sekine ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Mesothelial Cells ◽  
Fish Analysis

Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens

2009 ◽  
Vol 37 (12) ◽  
pp. 885-890 ◽  
Author(s):  
Noriko Kimura ◽  
Kimiko Dota ◽  
Yoshikazu Araya ◽  
Takuzo Ishidate ◽  
Masanori Ishizaka
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Scoring System ◽  
Mesothelial Cells

scholarly journals Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma

Cancer ◽  
2000 ◽  
Vol 90 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Hiromi Kitazume ◽  
Kazuhisa Kitamura ◽  
Katsuhiko Mukai ◽  
Yoshiaki Inayama ◽  
Naomi Kawano ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Mesothelial Cells

The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının

2016 ◽  
Vol 23 (3) ◽  
pp. 487-491 ◽  
Author(s):  
Nurhan Sahin ◽  
Ayse Nur Akatli ◽  
Muhammet Reha Celik ◽  
Hakkı Ulutas ◽  
Emine Turkmen Samdanci ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Pulmonary Carcinoma ◽  
Pleural Malignant Mesothelioma

scholarly journals Cytological differential diagnosis of reactive mesothelia and epithelial malignant mesothelioma in effusion fluid

2009 ◽  
Vol 48 (5) ◽  
pp. 327-335 ◽  
Author(s):  
Kunimitsu KAWAHARA ◽  
Teruaki NAGANO ◽  
Shigekatsu OHYAMA ◽  
Koji ASAI ◽  
Yaeko NOBE ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Effusion Fluid

Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Özlem Özmen ◽  
Ebru Tatci ◽  
Ş. Mustafa Demiröz ◽  
Zuhal Tazeler ◽  
Funda Demirağ
Keyword(s):  
Differential Diagnosis ◽  
Malignant Mesothelioma ◽  
Fdg Pet ◽  
Pet Ct ◽  
Tuberculous Pleurisy ◽  
18F Fdg ◽  
Fdg Pet Ct

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group

2009 ◽  
Vol 133 (8) ◽  
pp. 1317-1331 ◽  
Author(s):  
Aliya N. Husain ◽  
Thomas V. Colby ◽  
Nelson G. Ordóñez ◽  
Thomas Krausz ◽  
Alain Borczuk ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Interest Group ◽  
Malignant Mesothelioma ◽  
Consensus Statement ◽  
Spindle Cell ◽  
Cytologic Diagnosis ◽  
Pathologic Diagnosis ◽  
Practical Guidelines ◽  
Colonic Adenocarcinomas ◽  
Sarcomatoid Mesothelioma

Abstract Context.—Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. Objective.—To develop practical guidelines for the pathologic diagnosis of MM. Data Sources.—A pathology panel was convened at the International Mesothelioma Interest Group biennial meeting (October 2006). Pathologists with an interest in the field also contributed after the meeting. Conclusions.—There was consensus opinion regarding (1) distinguishing benign from malignant mesothelial proliferations (both epithelioid and spindle cell lesions), (2) cytologic diagnosis of MM, (3) key histologic features of pleural and peritoneal MM, (4) use of histochemical and immunohistochemical stains in the diagnosis and differential diagnosis of MM, (5) differentiating epithelioid MM from various carcinomas (lung, breast, ovarian, and colonic adenocarcinomas and squamous cell and renal cell carcinomas), (6) diagnosis of sarcomatoid mesothelioma, (7) use of molecular markers in the differential diagnosis of MM, (8) electron microscopy in the diagnosis of MM, and (9) some caveats and pitfalls in the diagnosis of MM. Immunohistochemical panels are integral to the diagnosis of MM, but the exact makeup of panels used is dependent on the differential diagnosis and on the antibodies available in a given laboratory. Immunohistochemical panels should contain both positive and negative markers. The International Mesothelioma Interest Group recommends that markers have either sensitivity or specificity greater than 80% for the lesions in question. Interpretation of positivity generally should take into account the localization of the stain (eg, nuclear versus cytoplasmic) and the percentage of cells staining (>10% is suggested for cytoplasmic membranous markers). These guidelines are meant to be a practical reference for the pathologist.

Sign in / Sign up

Export Citation Format

Share Document